| Excess mortality in Massachusetts during the Delta and Omicron waves of COVID-19 JS Faust, C Du, C Liang, KD Mayes, B Renton, K Panthagani, ... Jama 328 (1), 74-76, 2022 | 59 | 2022 |
| Uncoupling of all-cause excess mortality from COVID-19 cases in a highly vaccinated state JS Faust, B Renton, AJ Chen, C Du, C Liang, SX Li, Z Lin, HM Krumholz The Lancet Infectious Diseases 22 (10), 1419-1420, 2022 | 18 | 2022 |
| The effect of cannabis policies on treatment outcomes for cannabis use among US adults JL Bourdon, MW Francis, L Jia, C Liang, HI Robinson, RA Grucza Journal of substance abuse treatment 131, 108535, 2021 | 8 | 2021 |
| Two years of COVID-19: Excess mortality by age, region, gender, and race/ethnicity in the United States during the COVID-19 pandemic, March 1, 2020, through February 28, 2022 JS Faust, C Du, B Renton, C Liang, AJ Chen, SX Li, Z Lin, M Nunez-Smith, ... medRxiv, 2022.08. 16.22278800, 2022 | 2 | 2022 |
| The uncoupling of all-cause excess mortality from Covid-19 cases and associated hospitalizations in late winter and spring of 2022 in a highly vaccinated state JS Faust, B Renton, AJ Chen, C Du, C Liang, SX Li, Z Lin, HM Krumholz medRxiv, 2022.07. 07.22277315, 2022 | 2 | 2022 |
| Treatment patterns, healthcare resource utilization, and costs in Medicare patients with diffuse large B-cell lymphoma: A retrospective claims analysis (2015–2020) MP Jun, A Mutebi, A Chhibber, C Liang, A Keshishian, A Wang, ... Journal of Medical Economics, 1-15, 2024 | | 2024 |
| Patterns of Care and Resource Use Among Elderly Relapsed/Refractory Follicular Lymphoma Patients: US Medicare Claims Analysis SB Chawla, S Yang, J He, M Jun, N Heaps, A Wang, J Yu, C Liang, ... Blood 142, 5158, 2023 | | 2023 |
| Considering Frailty in Addition to Other Clinical Risk Variables in Medicare Fee-for-Service Heart Failure Mortality Risk Adjustment Cohort 2017-2019 K Sahay, C Liang, E Bean, S Brewer, Z Lin, K Dorsey-Sheares, SX Li, ... 2022 Annual Research Meeting, 2022 | | 2022 |
